Reducing the COVID-19 burden: diagnostics and the patient pathway
Tony Cambridge looks at a changing healthcare landscape as the service continues to respond to the ongoing coronavirus pandemic, and considers the important role of point-of-care tests and combination testing.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
For over 40 years Alpha Laboratories has been providing quality supply and support to UK healthcare professionals for their diagnostic and laboratory product needs. With a continued drive to find new ways to help science improve people’s lives, it focuses on specialist biomarkers such as calprotectin for IBD, alongside routine...